RPG Active Pharma approves merger with Actis Generics
after close1 source ↓written by the desknot a recommendation
RPG Active Pharma Limited has approved the merger of its wholly owned subsidiary, Actis Generics Private Limited, effective from 25 Sep 2026. This strategic consolidation aims to reduce administrative costs and enhance operational efficiency. Actis Generics reported revenue of ₹45.96 cr and net worth of ₹34.60 cr in FY26, which will now consolidate into RPG Active Pharma.
Not investment advice. For informational purposes only.